About Genomic Prediction
Genomic Prediction is a company based in North Brunswick (United States) founded in 2017. It operates as a B2B. Genomic Prediction has raised $4.5 million across 1 funding round from investors including Nimble Ventures and PeopleFund. Genomic Prediction operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Auxogyn, Overture Life and Clinical Microbiomics, among others.
- Headquarter North Brunswick, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.5 M (USD)
in 1 rounds
-
Latest Funding Round
$4.5 M (USD), Series A
Jan 31, 2019
-
Investors
Nimble Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Genomic Prediction
Unlock access to complete
Unlock access to complete
Funding Insights of Genomic Prediction
Genomic Prediction has successfully raised a total of $4.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.5 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genomic Prediction
Genomic Prediction has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Nimble Ventures and PeopleFund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by Nimble Ventures.
|
Locked | Locked | Locked | |
|
Seed to growth stage tech-focused VC and PE firm investing in geographies such as the US
|
Locked | Locked | Locked |
Investor details for Genomic Prediction
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genomic Prediction
Investment portfolio details for Genomic Prediction
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genomic Prediction
Detailed financials for Genomic Prediction
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genomic Prediction Comparisons
Peer comparison for Genomic Prediction
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genomic Prediction
Genomic Prediction operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Auxogyn, Overture Life and Clinical Microbiomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for IVF embryo viability assessment are developed.
|
|
| Locked | Locked | Locked |
Embryology diagnosis devices are developed for medical professionals.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
Detailed competitors of Genomic Prediction
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genomic Prediction
Complete news archive for Genomic Prediction
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genomic Prediction
Genomic Prediction was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Genomic Prediction is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
Genomic Prediction is a funded company, having raised a total of $4.5M across 1 funding round to date.
Genomic Prediction operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and ivf testing. Offers genomics tests to predict health outcomes for IVF procedures. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Genomic Prediction's top competitors include Novogene Corporation, BGI and Overture Life.
Genomic Prediction has 2 investors. Key investors include Nimble Ventures, and PeopleFund.